Valeant Pharmaceuticals International, Inc. (VRX) Stock Rating Reaffirmed by Wells Fargo & Company

Gladys Abbott
August 10, 2017

Citigroup holds 0% in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) or 137,268 shares. The Lmm Llc holds 4.86 million shares with $70.50 million value, up from 2.29 million last quarter. Valeant Pharmaceuticals Intl now has $5.31B valuation. The stock declined 10.29% or $1.61 reaching $14.03 on the news. During its last trading session, Stock traded with the total exchanged volume of 38.97 million shares. On average, equities analysts forecast that Valeant Pharmaceuticals International, Inc. will post $3.89 earnings per share for the current year. It has underperformed by 65.21% the S&P500.

Credit Agricole S A decreased Green Plains Renewable Energy Inc (GPRE) stake by 37.67% reported in 2016Q4 SEC filing. Brookfield Asset owns 73,189 shares. As per Thursday, May 11, the company rating was maintained by BMO Capital Markets. Teacher Retirement Systems Of Texas accumulated 225,900 shares or 0.02% of the stock. About 19.85 million shares traded or 15.47% up from the average. The Providence Service Corporation (NASDAQ:PRSC) has declined 2.07% since August 9, 2016 and is downtrending. It has outperformed by 16.47% the S&P500. It's up 0.12, from 0.52 in 2016Q3. The stock declined 2.62% or $0.85 reaching $31.65 per share. 39 funds opened positions while 57 raised stakes. Howe And Rusling holds 0% or 300 shares. Tobam accumulated 0.58% or 987,118 shares. Next Fincl Group Inc Incorporated reported 3,992 shares. Citadel Lc invested in 0% or 41,869 shares. 9,920 are held by Blackrock Inc. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika's affiliates. 173,290 are held by Northern Tru. Secor LP has 68,048 shares for 0.32% of their portfolio. The stock was purchased at an average price of C$13.90 per share, for a total transaction of C$278,000.00. California Public Employees Retirement invested in 144,900 shares or 0% of the stock.

Since June 1, 2017, it had 1 insider buy, and 0 sales for $49,821 activity. MAPES MICHELLE had sold 4,000 shares worth $102,010 on Wednesday, May 10.

Valeant said it earned $1.05 per share excluding items, coming in ahead of the average analyst estimate of 94 cents, according to Thomson Reuters I/B/E/S.

More news: Peepli Live actor Sitaram Panchal dies at the age of 54

VRX has been the topic of a number of recent research reports. The stock's market capitalization is $6.21 billion. On Wednesday, November 11 the stock rating was maintained by RBC Capital Markets with "Outperform". Finance Architects invested 0% in Lumber Liquidators Holdings Inc (NYSE:LL).

Since March 13, 2017, it had 3 buys, and 1 sale for $166.26 million activity. The company's shares were assimilated at $10.8 per share worth to an investment of some $108,000 on account of DE SCHUTTER RICHARD U. Pershing Square Capital Management - L.P. had sold 18.11 million shares worth $199.26 million. Moreover, Shell Asset Management has 0.02% invested in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) for 34,871 shares.

Valeant Pharmaceuticals International, Inc. (NYSE:GCO) on Thursday, June 1. Petroleo Brasileiro Sa Petro (Call) was reduced too. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. Therefore 22% are positive. Valeant Pharmaceuticals Intl had 116 analyst reports since July 21, 2015 according to SRatingsIntel. (NYSE:GCO) has "Strong Buy" rating given on Thursday, October 8 by CL King. The rating was maintained by Canaccord Genuity on Wednesday, March 16 with "Hold". As per Tuesday, March 15, the company rating was downgraded by Piper Jaffray. Oppenheimer has "Buy" rating and $3400 target. (VRX - Free Report) surged 1.76% after the company announced that it is on target with its debt reduction plans. The firm has "Buy" rating given on Wednesday, September 30 by Bank of America. On Tuesday, August 9 the stock rating was maintained by Rodman & Renshaw with "Buy".

Investors sentiment decreased to 0.78 in Q4 2016. Its up 0.15, from 0.98 in 2016Q3. It worsened, as 82 investors sold VRX shares while 87 reduced holdings. 49 funds opened positions while 82 raised stakes. Flow Traders Us Ltd Liability Co reported 18,949 shares or 0.02% of all its holdings. Aviva Plc invested in 0.02% or 209,043 shares. Stifel reported 159,270 shares stake. Vanguard Group Inc. raised its stake in Valeant Pharmaceuticals International by 9.8% in the first quarter. State Treasurer State Of Michigan has invested 0.04% in Valeant Pharmaceuticals Intl Inc (NYSE:VRX). New York-based Tower Ltd Liability Corporation (Trc) has invested 0% in Valeant Pharmaceuticals Intl Inc (NYSE:VRX). Bancshares Of Ny Mellon Corp holds 702,751 shares. Rbf Cap Limited Liability reported 90,100 shares or 0.2% of all its holdings.

Other reports by LeisureTravelAid

Discuss This Article